drugset / Trial / NCT03307720

Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)

NCT03307720

Unknown 300 enrolled Ginegorama S.L.
RandomizedParallel-groupOpen-labelTreatment

Summary

Agonist triggering in controlled ovarian stimulation protocols is being used during last years (among high responder patients to avoid OHSS). Indeed, agonist triggering is more physiologic than HCG triggering. Investigators propose to compare the effectiveness of both types of trigger among three different subsets of patients: 1. Poor responders. 2. Normo-responders 3. High responders Comparing both the number and the quality of achieved oocytes.

Timeline

Start
2017-12-18
Primary completion
2018-02
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptoreline Unknown 0.2 mg Subcutaneous
Comparator human chorionic gonadotropin Protein / enzyme biologic 250 iu Subcutaneous